[Federal Register Volume 89, Number 50 (Wednesday, March 13, 2024)]
[Notices]
[Pages 18424-18425]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05300]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Infant and Maternal 
Mortality

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Infant and Maternal 
Mortality (ACIMM or Committee) has scheduled a public meeting. 
Information about ACIMM and the agenda for this meeting can be found on 
the ACIMM website at https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

DATES: 
     April 2, 2024, 9 a.m. to 4 p.m. Central Time (CT);
     April 3, 2024, 12 p.m. to 6 p.m. CT; and
     April 4, 2024, 9 a.m. to 12 p.m. CT.

ADDRESSES: This meeting will be held in-person at Delmar Divine, 5501 
Delmar Boulevard, St. Louis, Missouri 63112 and virtually via webinar. 
The webinar link and log-in information will be available at the ACIMM 
website before the meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/index.html.

FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Designated Federal 
Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, 
Rockville, Maryland 20857; 301-443-0543; or [email protected].

SUPPLEMENTARY INFORMATION: ACIMM is authorized by section 222 of the 
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee 
is governed by provisions of the Federal Advisory Committee Act (5 
U.S.C. Chapter 10), as amended.
    ACIMM advises the Secretary of Health and Human Services 
(Secretary) on department activities, partnerships, policies, and 
programs directed at reducing infant mortality, maternal mortality and 
severe maternal morbidity, and improving the health status of infants 
and women before, during, and after pregnancy. The Committee provides 
advice on how to coordinate federal, state, local, tribal, and 
territorial governmental efforts designed to improve infant mortality, 
related adverse birth outcomes, maternal health, as well as influence

[[Page 18425]]

similar efforts in the private and voluntary sectors. The Committee 
provides guidance and recommendations on the policies, programs, and 
resources required to address the disparities and inequities in infant 
mortality, related adverse birth outcomes and maternal health outcomes, 
including maternal mortality and severe maternal morbidity. With its 
focus on underlying causes of the disparities and inequities seen in 
birth outcomes for women and infants, ACIMM advises the Secretary on 
the health, social, economic, and environmental factors contributing to 
the inequities and proposes structural, policy, and/or systems level 
changes.
    The agenda for the April 2-4, 2024, meeting is being finalized and 
may include the following topics: updates on the federal Healthy Start 
program; Committee discussions on the workgroup topics of rural health 
care access, social drivers of health, and women's health before/
between pregnancies; federal updates; and remarks from individuals with 
lived experience and community members, including those representing 
community-based organizations, on how to achieve optimal maternal 
health and overall birth outcomes for underserved populations, 
including Black/African-American families. Agenda items are subject to 
change as priorities dictate. Refer to the ACIMM website listed above 
for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide written 
or oral comments. Requests to submit a written statement or make oral 
comments to ACIMM should be sent to Vanessa Lee, using the email 
address above at least 3 business days prior to the meeting. Public 
participants may submit written statements in advance of the scheduled 
meeting by emailing [email protected]. Oral comments will be honored in 
the order they are requested and may be limited as time allows.
    Individuals who plan to attend and need special assistance or a 
reasonable accommodation should notify Vanessa Lee at the contact 
information listed above at least 10 business days prior to the 
meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-05300 Filed 3-12-24; 8:45 am]
BILLING CODE 4165-15-P